This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, T.
Right arrow Articles by DiAugustine, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, T.
Right arrow Articles by DiAugustine, R. P.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, June 2005, p. 5270-5281, Vol. 25, No. 12
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.12.5270-5281.2005

Conditional Transgenic System for Mouse Aurora A Kinase: Degradation by the Ubiquitin Proteasome Pathway Controls the Level of the Transgenic Protein

Tomokazu Fukuda,1 Yuji Mishina,2 Michael P. Walker,1 and Richard P. DiAugustine1*

Hormones and Cancer Group, Laboratory of Molecular Carcinogenesis,1 Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 277092

Received 30 December 2004/ Returned for modification 26 February 2005/ Accepted 16 March 2005

Aurora A is a mitotic kinase that localizes to centrosomes. Expression of this protein is normally limited to the mitotic stage (G2-M) of the cell cycle, whereas human cancer cells frequently exhibit overexpression of Aurora A protein regardless of the cell cycle stage. In the present study, Aurora A transgenic mouse lines were generated with a new conditional expression system (cytomegalovirus immediate early enhancer-chicken beta-actin hybrid promoter-Z-enhanced green fluorescent protein) in order to analyze the function of this protein. Although transcripts for Aurora A were elevated in multiple organs of the transgenic mice, the corresponding protein was not detected in extracts analyzed by immunoblotting. The treatment of transgenic-derived embryonic fibroblasts (MEF) with proteasome inhibitors markedly increased the protein level of transgenic Aurora A, indicating that the transgenic Aurora A protein is readily degraded in normal mouse tissues. Under the exponential growth conditions of MEF cells, transgenic Aurora A was detected within the mitotic stage of the cell cycle and localized to centrosomes. In contrast, the marker of the transgenic promoter (enhanced green fluorescent protein) was continuously expressed throughout the cell cycle, indicating the constitutive transcription of transgenic mRNA. These results indicate that transgenic Aurora A is protected from degradation within G2-M but is immediately degraded after translation in the G1-S stage of the cell cycle. The findings obtained with this transgenic model and derived cells support that the transition from protection to degradation by the ubiquitin proteasome system at the end of mitosis is an important step in controlling the level of Aurora A protein during the cell cycle.


* Corresponding author. Mailing address: Hormones and Cancer Group, Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Mail Drop D4-04, Research Triangle Park, NC 27709. Phone: (919) 541-5080. Fax: (919) 541-0146. E-mail: diaugus2{at}niehs.nih.gov.


Molecular and Cellular Biology, June 2005, p. 5270-5281, Vol. 25, No. 12
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.12.5270-5281.2005




This article has been cited by other articles:

  • Torchia, E. C., Chen, Y., Sheng, H., Katayama, H., Fitzpatrick, J., Brinkley, W. R., Caulin, C., Sen, S., Roop, D. R. (2009). A Genetic Variant of Aurora Kinase A Promotes Genomic Instability Leading to Highly Malignant Skin Tumors. Cancer Res. 69: 7207-7215 [Abstract] [Full Text]  
  • Li, C.-C., Chu, H.-Y., Yang, C.-W., Chou, C.-K., Tsai, T.-F. (2009). Aurora-A Overexpression in Mouse Liver Causes p53-Dependent Premitotic Arrest during Liver Regeneration. Mol Cancer Res 7: 678-688 [Abstract] [Full Text]  
  • Cowley, D. O., Rivera-Perez, J. A., Schliekelman, M., He, Y. J., Oliver, T. G., Lu, L., O'Quinn, R., Salmon, E. D., Magnuson, T., Van Dyke, T. (2009). Aurora-A Kinase Is Essential for Bipolar Spindle Formation and Early Development. Mol. Cell. Biol. 29: 1059-1071 [Abstract] [Full Text]  
  • Gray, D., Jubb, A. M., Hogue, D., Dowd, P., Kljavin, N., Yi, S., Bai, W., Frantz, G., Zhang, Z., Koeppen, H., de Sauvage, F. J., Davis, D. P. (2005). Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers. Cancer Res. 65: 9751-9761 [Abstract] [Full Text]